A diabetes risk assessment system and assessment method based on obesity
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 北京健康有益科技有限公司
- Publication Date
- 2022-04-26
Smart Images

Figure 1 
Figure 2
Abstract
Description
Technical field
[0001] The present application relates to the field of diabetes risk assessment techniques, in particular to a diabetes risk assessment system and assessment method based on obesity. Background
[0002] According to the data of existing technical research, obesity and diabetes are both metabolic diseases, and obesity is closely related to the occurrence of diabetes. Diabetes occurs mainly due to the decline of islet β cell function and insulin resistance, which is a key factor in obesity. Obese patients due to excessive weight, high fat content, it is easy to produce insulin resistance, insulin resistance so that the body's insulin can not play a corresponding hypoglycemic effect. Since insulin is the only hypoglycemic hormone in the body, the body must improve the ability of islet β cells to secrete insulin, increase insulin secretion, when increasing insulin secretion still can not restore blood sugar to normal will lead to diabetes, so insulin resistance is on...